CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.
September 22nd 2021, 7:00pm
The tome also reflects on his own diagnosis of cancer and how it influenced his practice.
September 22nd 2021, 4:05pm
The FDA approval of Cabometyx was based on results that showed that the drug was associated with improved outcomes in patients with radioactive iodine–refractory locally advanced or metastatic differentiated thyroid cancer.
September 20th 2021, 10:30pm
View the full CURE® Educated Patient® Webinar: Treatment and Care for Thyroid Cancer on demand.
July 28th 2021, 2:04pm
Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.
July 28th 2021, 1:58pm
The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.
July 21st 2021, 5:48pm
Current barriers that impact patient access to comprehensive biomarker testing in the community and efforts underway to help advocate for increased accessibility to molecular assays moving forward.
July 21st 2021, 4:05pm
Resources available to support patients and community oncologists who are interested in learning more and gaining access to comprehensive biomarker testing.
June 23rd 2021, 2:06pm
Lori J. Wirth, MD, describes what information she looks for from results of molecular testing that help inform treatment for her patients with thyroid cancer.
June 23rd 2021, 1:58pm
Andrea Ferris, of the LUNGevity Foundation, explains why shared decision-making is important when recommending molecular testing to patients with lung or thyroid cancer and highlights resources provided through her organization that support patients and health care professionals.
June 16th 2021, 3:21pm
Common questions asked by patients with lung or thyroid cancer who have been referred for biomarker testing and advice for setting expectations from test results.
FDA OKs Imfinzi for Limited-Stage Small Cell Lung Cancer
FDA Approves Bizengri for Some with NSCLC, Pancreatic Adenocarcinoma
Expert Explains Lymphoma After Dave Coulier's Diagnosis
Time, My Most Precious Gift After Breast Cancer